<DOC>
	<DOCNO>NCT02534688</DOCNO>
	<brief_summary>randomize controlled trial Eligiblility criterion Provisional diagnosis Clinical presentation Progressive dysmenorrhea Chronic pelvic pain Deep dyspareunia Evidences endometriosis Endometriotic nodule Cul-de-sac nodularity Endometrioma detect ultrasonography size &lt; 4 cm Inclusion criterion Female age 18-45 yr Moderate severe pelvic pain categorize VAS &gt; 50 Previous sexual intercourse Exclusion criterion Co-existing genital tract disease associate pain Previous hormonal use within 3 month History DMPA treatment failure WHO eligibility criterion 2009 DMPA LNG-IUS Category 3,4 Fertility desire upcoming 1 year Primary objective To compare efficacy pain control endometriosis associate pelvic pain LNG-IUS DMPA Secondary objective To compare side effect , continuation rate , satisfaction quality life LNG-IUS DMPA treatment endometriosis associate pelvic pain Primary outcome Severity pelvic pain Measured VAS score 0 mean pain 100 mean pain Secondary outcomes Vaginal bleeding pattern Side effect systemic progestogen Lipid profile Weight gain Quality life Measured quesionaire SF36 Satisfaction Measrured linket scale 0-4 0 mean dissatisfy 1 dissatisfied 2 satisfy dissatiffied 3 satisfy 4 satisfied Continuation rate Endometrioma size reduction</brief_summary>
	<brief_title>Effectiveness Levonorgestrel-intrauterine System ( LNG-IUS ) Versus Depot Medroxyprogesterone Acetate ( DMPA ) Treatment Pelvic Pain Clinically Diagnosed Endometriotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Female age 1845 yr Moderate severe pelvic pain categorize VAS &gt; 50 Previous sexual intercourse Coexisting genital tract disease associate pain Previous hormonal use within 3 month History DMPA treatment failure WHO eligibility criterion 2009 DMPA LNGIUS Category 3,4 Fertility desire upcoming 1 year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>